Literature DB >> 20887332

Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance.

Tatsuki Ichikawa1, Taura Naota, Hisamitsu Miyaaki, Satoshi Miuma, Hajime Isomoto, Fuminao Takeshima, Kazuhiko Nakao.   

Abstract

AIM: Sleep is closely related to physical and mental health. Sleep disturbance is reported in patients without encephalopathy. We examined the relationship among cirrhotic symptoms, laboratory data and sleep disturbances. Next, we examined the influence of a branched chain amino acid (BCAA) supplement on sleep disturbance in cirrhotic patients.
METHODS: We investigated a total of 21 patients at Nagasaki University Hospital from January to June 2009. We constructed questionnaire items for the evaluation of cirrhotic symptoms. The items, as major symptoms of cirrhotic patients, were as follows: hand tremor, appetite loss, muscle cramp of foot, fatigue, decreased strength, anxiety, abdominal fullness, abdominal pain and a feeling of low energy. We used the Epworth Sleepiness Scale (ESS) for the evaluation of daytime hypersomnolence. Energy supplementation with a BCAA snack was performed as a late evening snack (LES). All patients were assessed at the time of entry into the study, and at 4 and 8 weeks.
RESULTS: It was found that BCAA snack, taken p.o. as an LES, improved the ESS for cirrhotic patients without encephalopathy. This beneficial result was recognized in the short term, 4 weeks after beginning of treatment. This study demonstrated the utility of BCAA supplementation for cirrhotic patients with sleep disturbance. However, the cirrhotic symptom-related score was positively relation with the Child-Pugh score at the time of patient entry, and we were unable to identify the item that related to ESS.
CONCLUSION: A BCAA snack is a useful drug for cirrhotic patients who do not have any overt encephalopathy, but who suffered from sleep disturbance.
© 2010 The Japan Society of Hepatology.

Entities:  

Year:  2010        PMID: 20887332     DOI: 10.1111/j.1872-034X.2010.00701.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  13 in total

Review 1.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.

Authors:  Han Ah Lee; Young Chang; Pil Soo Sung; Eileen L Yoon; Hye Won Lee; Jeong-Ju Yoo; Young-Sun Lee; Jihyun An; Do Seon Song; Young Youn Cho; Seung Up Kim; Yoon Jun Kim
Journal:  Clin Mol Hepatol       Date:  2022-07-01

3.  The Usefulness of the Athens Insomnia Scale for Evaluating Sleep Disturbance in Patients with Chronic Liver Disease Comparing with Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale.

Authors:  Hideto Kawaratani; Hisamitsu Miyaaki; Atsushi Hiraoka; Kazuhiko Nakao; Yoichi Hiasa; Hitoshi Yoshiji; Kiwamu Okita; Kazuhiko Koike
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

Review 4.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

5.  Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis.

Authors:  Jayanta Samanta; Radha K Dhiman; Amit Khatri; Kiran K Thumburu; Sandeep Grover; Ajay Duseja; Yogesh Chawla
Journal:  Metab Brain Dis       Date:  2013-03-15       Impact factor: 3.584

Review 6.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

7.  Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis.

Authors:  Masafumi Haraguchi; Hisamitsu Miyaaki; Tatsuki Ichikawa; Hidetaka Shibata; Takuya Honda; Eisuke Ozawa; Satoshi Miuma; Naota Taura; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Hepatol Int       Date:  2016-09-13       Impact factor: 6.047

8.  Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.

Authors:  Emi Yoshimura; Tatsuki Ichikawa; Hisamitsu Miyaaki; Naota Taura; Satoshi Miuma; Hidataka Shibata; Takuya Honda; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Biomed Rep       Date:  2016-06-13

9.  Assessment of sleep pattern and quality before and after liver transplantation using different methods.

Authors:  Genco Gençdal; Gamze Türker; Işıl Yazıcı Gençdal; Burçak Ekinci; Şencan Acar; Ayhan Dinçkan; Murat Akyıldız
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

Review 10.  Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.

Authors:  Hitoshi Yoshiji; Sumiko Nagoshi; Takemi Akahane; Yoshinari Asaoka; Yoshiyuki Ueno; Koji Ogawa; Takumi Kawaguchi; Masayuki Kurosaki; Isao Sakaida; Masahito Shimizu; Makiko Taniai; Shuji Terai; Hiroki Nishikawa; Yoichi Hiasa; Hisashi Hidaka; Hiroto Miwa; Kazuaki Chayama; Nobuyuki Enomoto; Tooru Shimosegawa; Tetsuo Takehara; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-07-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.